# A Study of LY3971297 in Participants With Heart Failure

> **NCT07547540** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 90 (estimated)

## Conditions studied

- Heart Failure
- Heart Failure, Diastolic
- Heart Failure, Systolic

## Interventions

- **DRUG:** LY3971297
- **DRUG:** LY3971297
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07547540
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07547540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07547540, "A Study of LY3971297 in Participants With Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07547540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*